EDITORIAL
Published on 07 Aug 2014
Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy
doi 10.3389/fphar.2014.00185
- 3,207 views
- 1 citation
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Engaging Novel Cell Types, Protein Targets and Efficacy Biomarkers in the Treatment of Diabetic Nephropathy
Engaging Novel Cell Types, Protein Targets and Efficacy Biomarkers in the Treatment of Diabetic Nephropathy
6,773
Total downloads
27k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 21 Apr 2014
Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes
doi 10.3389/fphar.2014.00071
- 4,239 views
- 13 citations
REVIEW
Published on 14 Apr 2014
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
doi 10.3389/fphar.2014.00070
- 5,990 views
- 28 citations
REVIEW
Published on 25 Feb 2014
Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease
doi 10.3389/fphar.2014.00023
- 8,511 views
- 44 citations
ORIGINAL RESEARCH
Published on 14 Oct 2013
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
doi 10.3389/fphar.2013.00115
- 5,457 views
- 50 citations
